Skip to main content

Nasdaq Stocks

Here's Why Range Resources (RRC) is Worth Betting on Now

6 years 5 months ago
Range Resources Corporation RRC has witnessed upward estimate revisions for its 2020 bottom-line in the past 30 days. In fact, six out of eight analysts have revised their estimates upward. Also, this leading upstream energy player’s stock price has surged 20.4% year to date.

Progressive's (PGR) April Earnings Rise on Higher Revenues

6 years 5 months ago
The Progressive Corporation PGR reported earnings per share of $1.62 for April 2020, soaring 96% year over year on an improved top line.Year to date, Progressive’s shares have gained 3.5% against the industry’s 24.8% decline. The rise was courtesy of the company’s sustaine

Reasons to Hold BHP Group (BHP) Stock in Your Portfolio Now

6 years 5 months ago
BHP Group BHP is poised well on solid cash generation, efforts to lower debt, investment in growth projects and higher operational efficacy aided by adoption of technology.At present, BHP Group carries a Zacks Rank #3 (Hold). It has a VGM Score of A. Our research shows that stoc

Microsoft (MSFT) Acquires Softomotive to Strengthen RPA

6 years 5 months ago
Microsoft MSFT announced the acquisition of robotic process automation (RPA) software provider Softomotive, during Build 2020 conference.However, the financial terms of the deal have been kept under wraps. Per Crunchbase data, Softomotive raised around $25 million in funding as

Why Dominion Energy (D) is a Good Stock to Buy Now

6 years 5 months ago
We recently updated a research report on Dominion Energy D. Dominion’s long-term investment plans, focus to add more renewable assets, expand natural gas business and strong liquidity makes it a good option to hold during this unprecedented economic crisis.Despite missing firs

Chubb (CB) Boosts Shareholder Value, Hikes Dividend by 4%

6 years 5 months ago
The board of directors of Chubb Limited CB recently approved a hike in its quarterly dividend. The company will now pay out a dividend of 78 cents per share compared with 75 cents paid on Jul 12, 2019, which reflects an increase of 4%.Shareholders of record as of Jun 19, 2020 wi

AstraZeneca/Merck's Lynparza Get FDA Nod for Prostate Cancer

6 years 5 months ago
AstraZeneca AZN and partner Merck MRK announced that the FDA has approved their PARP inhibitor Lynparza for the fourth cancer type — prostate cancer. The FDA approved Lynparza for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC), who have a mut
Checked
12 minutes 56 seconds ago
This feed is responsible for generating the rss feed related to the topic Stocks
Subscribe to Nasdaq Stocks feed